Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate fromSubject ▲
 20.6.2019KRKA, d.d., Novo mesto (KRK-2)45300Azibiot (tbl flm 3x500 mg)1.7.2019Z
 18.6.2019B.Braun Melsungen AG (BME)05628NuTRIflex Omega plus (emu inf 5x2500 ml (vak.PA/PP - viackomor.))17.6.2019Z
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)86630Temomedac 20 mg tvrdé kapsuly (cps dur 5x20 mg (fľa.skl.))15.8.2019Z
 24.4.2019GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)37364Voltaren Emulgel (gel 1x50 g (tuba lamin.LDPE/Al/HDPE))24.4.2019Z
 12.6.2019KRKA, d.d., Novo mesto (KRK-2)45300Azibiot (tbl flm 3x500 mg)24.6.2019Z
 15.4.2019Eli Lilly Nederland B.V. (LIL-NL-2)41437ALIMTA 500 mg prášok na infúzny koncentrát (plc ifc 1x500 mg (liek.inj.skl.))31.7.2019Z
 10.6.2019Boehringer Ingelheim International GmbH (BOE)57363Aggrenox, 200/25 mg tvrdé kapsuly s riadeným uvoľňovaním (cps mdd 30x200 mg/25 mg (liek.PP))30.7.2019Z
 6.6.2019B.Braun Melsungen AG (BME)87154Braunovidon (lig imp 10x7,5x10 cm (obal hliníkový))7.6.2019Z
 6.6.2019B.Braun Melsungen AG (BME)87155Braunovidon (lig imp 10x20x10 cm (obal hliníkový))7.6.2019Z
 5.6.2019MSD VACCINS (MSD-FR)36410ZOSTAVAX prášok a disperzné prostredie na injekčnú suspenziu v naplnenej injekčnej striekačke (plv iul 1x >19 400 PFU +1x solv. (skl.liek.+napl.skl.striek.s 2 samost.ihlami))15.9.2019Z
 5.6.2019Corza Medical GmbH (CRZ)2309BTachoSil matrica s tkanivovým lepidlom (mat gtv 1x(4,8 cmx4,8 cm) (blis.Al))5.6.2019Z
 31.5.2019Mylan IRE Healthcare Limited (MYR)12517Breakyl 400 mikrogramov (flm buc 28x400 µg (vre.PAN/Al/PA/lamin.pap.-povolenie uvádzať na trh končí dňa 20.05.2019))20.5.2019Z
 31.5.2019Mylan IRE Healthcare Limited (MYR)12514Breakyl 200 mikrogramov (flm buc 28x200 µg (vre.PAN/Al/PA/lamin.pap.-povolenie uvádzať na trh končí dňa 20.05.2019))20.5.2019Z
 2.5.2019Sandoz Pharmaceuticals d.d. (SAN-SLO-1)36467Vinorelbin "Ebewe" 10 mg/ ml infúzny koncentrát (con inf 1x5 ml/50 mg (liek.inj.skl.))15.5.2019Z
 22.7.2019Glenmark Pharmaceuticals s.r.o. (GLM-CZ)86798ULPRIX 40 mg (tbl ent 100x40 mg (blis.OPA/Al/PVC/Al))30.9.2019Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)